Provided by Tiger Trade Technology Pte. Ltd.

Geron

1.55
0.0000
Post-market: 1.54-0.0098-0.63%19:56 EDT
Volume:22.19M
Turnover:33.28M
Market Cap:989.45M
PE:-12.38
High:1.56
Open:1.53
Low:1.44
Close:1.55
52wk High:2.01
52wk Low:1.04
Shares:638.36M
Float Shares:534.08M
Volume Ratio:1.42
T/O Rate:4.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1252
EPS(LYR):-0.1252
ROE:-32.99%
ROA:-5.53%
PB:4.38
PE(LYR):-12.38

Loading ...

Stock Track | Geron (GERN) Plunges 5.50% After Mixed Q3 Earnings Report

Stock Track
·
Nov 06, 2025

Stock Track | Geron Plunges 5.50% Following Mixed Q3 Earnings Report and Missed Revenue Target

Stock Track
·
Nov 06, 2025

Stock Track | Geron Soars 5.50% Despite Mixed Q3 Results as Analysts Maintain Positive Outlook

Stock Track
·
Nov 06, 2025

Stock Track | Geron Soars 5.50% After Q3 Earnings and Maintained Buy Ratings

Stock Track
·
Nov 06, 2025

Geron Corporation’s Earnings Call: Mixed Sentiments and Future Prospects

TIPRANKS
·
Nov 06, 2025

Buy Rating Maintained for Geron Despite Rytelo Sales Dip, Strong Financial Position Supports Strategic Shift

TIPRANKS
·
Nov 06, 2025

Geron Is Maintained at Buy by Needham

Dow Jones
·
Nov 06, 2025

Strategic Initiatives and Market Expansion Drive Buy Rating for Geron

TIPRANKS
·
Nov 06, 2025

Stock Track | Geron Plummets 5.22% Pre-market After Q3 Revenue Miss Despite In-Line EPS

Stock Track
·
Nov 05, 2025

Stock Track | Geron Soars 8.70% Pre-Market on Strong Q3 Results and Improved 2025 Outlook

Stock Track
·
Nov 05, 2025

Geron reports Q3 EPS (3c), consensus (4c)

TIPRANKS
·
Nov 05, 2025

Stock Track | Geron Plunges 5.22% Pre-market Following Q3 Sales Miss

Stock Track
·
Nov 05, 2025

Geron Expects 2025 Operating Expenses Will Be Between $250M And $260M vs. Approximately $270M-$285M Prior

Benzinga
·
Nov 05, 2025

Geron Q3 EPS $(0.03), Inline, Sales $47.227M Miss $52.881M Estimate

Benzinga
·
Nov 05, 2025

Hematology drug developer Geron Q3 narrows net loss narrows, driven by RYTELO sales

Reuters
·
Nov 05, 2025

BRIEF-Geron Q3 EPS USD -0.03

Reuters
·
Nov 05, 2025

Geron Corp 2025 Outlook Expects Total Operating Expenses Will Be Between $250 Mln and $260 Mln

THOMSON REUTERS
·
Nov 05, 2025

Geron Corporation CEO to Present at Stifel Healthcare Conference

Reuters
·
Nov 04, 2025

Geron Highlights New RYTELO Clinical Data in Myeloid Malignancies at ASH 2025

Reuters
·
Nov 03, 2025

Press Release: Geron Plans to Announce Third Quarter 2025 Financial Results on November 5, 2025

Dow Jones
·
Oct 27, 2025